![Rebecca Luse](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rebecca Luse
Direktor/Vorstandsmitglied bei Tourmaline Bio, Inc.
Aktive Positionen von Rebecca Luse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tourmaline Bio, Inc.
![]() Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Direktor/Vorstandsmitglied | - | - |
Deep Track Capital LP
![]() Deep Track Capital LP Financial ConglomeratesFinance Deep Track Capital LP provides investment advice. The private company is based in Greenwich, CT and has subsidiaries in Cayman Islands. The company was founded in 2020 by David Eric Kroin. David Eric Kroin has been the CEO since 2020. | Private Equity Investor | 01.01.2021 | - |
Karriereverlauf von Rebecca Luse
Ehemalige bekannte Positionen von Rebecca Luse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bay City Capital LLC
![]() Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Corporate Officer/Principal | - | - |
Ausbildung von Rebecca Luse
Indiana University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sektoral
Finance | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Bay City Capital LLC
![]() Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
Tourmaline Bio, Inc.
![]() Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Commercial Services |
Deep Track Capital LP
![]() Deep Track Capital LP Financial ConglomeratesFinance Deep Track Capital LP provides investment advice. The private company is based in Greenwich, CT and has subsidiaries in Cayman Islands. The company was founded in 2020 by David Eric Kroin. David Eric Kroin has been the CEO since 2020. | Finance |
- Börse
- Insiders
- Rebecca Luse
- Erfahrung